Ginkgo Bioworks Holdings Operating Income 2020-2022 | DNA
Ginkgo Bioworks Holdings annual/quarterly operating income history and growth rate from 2020 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Ginkgo Bioworks Holdings operating income for the quarter ending March 31, 2022 was $-0.675B, a 1080.98% increase year-over-year.
- Ginkgo Bioworks Holdings operating income for the twelve months ending March 31, 2022 was $-2.446B, a 2572.26% increase year-over-year.
- Ginkgo Bioworks Holdings annual operating income for 2021 was $-1.828B, a 1234.38% increase from 2020.
- Ginkgo Bioworks Holdings annual operating income for 2020 was $-0.137B, a 91.38% increase from 2019.
- Ginkgo Bioworks Holdings annual operating income for 2019 was $-0.072B, a INF% decline from .
Ginkgo Bioworks Holdings Annual Operating Income
(Millions of US $) |
| 2021 |
$-1,828 |
| 2020 |
$-137 |
| 2019 |
$-72 |
Ginkgo Bioworks Holdings Quarterly Operating Income
(Millions of US $) |
| 2022-03-31 |
$-675 |
| 2021-12-31 |
$-1,739 |
| 2021-09-30 |
$-27 |
| 2021-06-30 |
$-5 |
| 2021-03-31 |
$-57 |
| 2020-12-31 |
|
| 2020-09-30 |
$-34 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$5.223B |
$0.314B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
